Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 29, 2022 06:24 ET | Source: Syneos Health, Inc.

Syneos Health Reports First Quarter 2022 Results

Highlights Revenue for the first quarter of $1,336.3 million increased 10.5% on a reported basis and 11.7% on a constant currency basis year-over-year.Clinical Solutions net new business...
April 19, 2022 08:00 ET | Source: Syneos Health, Inc.

Syneos Health Promotes Baba Shetty to President, Technology and Data Solutions, and Suma Ramadas to Executive Vice President, Medical Affairs

MORRISVILLE, N.C., April 19, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the promotions of two senior...
April 11, 2022 16:05 ET | Source: Syneos Health, Inc.

Syneos Health Schedules First Quarter 2022 Earnings Call for Friday, April 29th, 2022

MORRISVILLE, N.C., April 11, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization purpose-built to accelerate customer success,...
February 17, 2022 06:10 ET | Source: Syneos Health, Inc.

Syneos Health Reports Fourth Quarter and Full Year 2021 Results

Highlights Fourth quarter revenue of $1,373.4 million increased 20.5% year-over-year.Clinical Solutions net new business awards and book-to-bill ratios: Including reimbursable out-of-pocket expenses,...
February 01, 2022 07:26 ET | Source: Syneos Health, Inc.

Syneos Health Schedules Fourth Quarter and Full Year 2021 Earnings Call for Thursday, February 17th, 2022

MORRISVILLE, N.C., Feb. 01, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization purpose-built to accelerate customer success,...
January 18, 2022 06:16 ET | Source: Syneos Health, Inc.

Syneos Health Appoints Two New Independent Directors

MORRISVILLE, N.C., Jan. 18, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced it has appointed two new...
January 11, 2022 09:00 ET | Source: Syneos Health, Inc.

Syneos Health Releases 2022 Dealmakers’ Intentions Survey

MORRISVILLE, N.C., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today released its 12th annual Dealmakers’...
January 04, 2022 09:06 ET | Source: Syneos Health, Inc.

Syneos Health to Present at the 40th Annual J.P. Morgan Healthcare Conference

MORRISVILLE, N.C., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization purpose-built to accelerate customer success,...
December 21, 2021 09:00 ET | Source: Syneos Health, Inc.

Syneos Health Releases 2022 Health Trends

MORRISVILLE, N.C., Dec. 21, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today released 2022 Health Trends: Insights for...
November 11, 2021 09:00 ET | Source: Syneos Health, Inc.

Syneos Health to Present at Upcoming Investor Conferences

MORRISVILLE, N.C., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that the Company is scheduled...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right